38 - Chronic stroke prevention Flashcards
- *SECONDARY Stroke Prevention**
- *AntiPlatelet Agents**
COX-I
Aspirin 81 > 325 qd
ADP Inhibitors
- *Ticlopidine 250mg BID w/food**
- *Clopidogrel 75mg qd**
PDE inhibitor + adenosine amplifier
Aggrenox
ASA 25mg / ERD 200mg BID
Secondary Stroke Prevention
CLOPIDOGREL
PRODRUG
Thienopyridine
Requires Loading dose:
- *300mg - 2 hours**
- *7mg - 2 days**
Secondary Stroke Prevention
AGGRENOX
ERD 200mg + ASA 25mg
BID
do NOT chew/crush/open capsule
SIDE EFFECTS:
- *HEADACHE 40%**
- *GI Pain / Diarrhea**
- *Better than Each agent ALONE**
- DOES NOT SAVE LIVES*
When would we use the combination of:
ASA + Clopidogrel?
MINOR STROKE** or **TIA
CHANCE 2013: NIHSS score < 3 or High Risk TIA ABCD2 Score > 4
Start BOTH within 24 hours of TIA/Stroke
VVV
continue for ONLY 21 DAYS
↓Stroke ↓MI/CV/Stroke Death
When would ANTIPLATELETS be preferred
> AntiCoagulants?
NON-CARDIOEMBOLIC STOKES
- *Primary Stroke Prevention**
- *RISK FACTORS**
Control:
HTN / Diabetes / Hyperlipidemia
TREAT:
AFIB
Diet / Exercise
SMOKING CESSATION
Secondary Stroke Prevention
RISK FACTORS
ALL PRIMARY
plus
CEA for carotid stenosis
AC for
Thromboembolic or hypercoagulable disease
Antiplatelet therapy
- *NON-MODIFIABLE**
- *STROKE RISK FACTORS**
AGE > 55
FAMILY HISTORY
RACE:
AA > hispanic/asian > caucasian
Gender M > F
Prior:
Stroke / TIA / MI
- *MODIFIABLE**
- *Stroke Risk Factors**
High BP / DM / AFIB
SMOKING
Poor Diet / Physical Inactivity / HYPERLIPIDemia
Heart Disease / Sickle Cell
Carotid/Peripheral Artery Disease
Modifiable Risk Factor
HYPERTENSION
Lowering BP can:
↓Stroke Risk by 30-40%
Treatment Recommendations:
< 130/80
uncertain benefit in pts W/O HTN
May initiate treatment >24-48 hours after acute stroke
Diuretics + ACE inhibitors
Modifiable Risk Factor
DIABETES
↑Risk of Recurrent stroke by 60%
present in 25-45% of ALL stroke patients
All Stroke pts. screened for DM:
Glucose >126 / HgbA1c _>_6.5%
***_NO single agent/class preferred_*** just want to be **CONTROLLED**
Modifiable Risk Factor
HYPERLIPIDEMIA
no evidence linking the
CHOLESTEROL LEVELS or LIPID LEVELSto STROKE
BUT:
SPARCL Trial showed in:
recent stroke/TIA + LDL 100-190 + NO HISTORY OF CAD
↓Stroke Recurrence w/ ATORVASTATIN
↓Stroke / TIA
ROLE of STATINS
In
Treatment / Prevention of Stroke
SPARCL TRIAL
Recent Stroke/TIA // LDL 100-190 // no h/o CAD
AHA/ASA recommends:
Intensive Statins for patients with:
Ischemic Stroke / TIA** of **Atherosclerotic Origin
AND
LDL > 100 but still recommended for LDL < 100
Modifiable Risk Factor
SMOKING
INCLUDES SECOND HAND SMOKE
- *2x Stroke Risk**
- risk decreases RIGHT AFTER quitting*
- *dissapears after 5 YEARS**
AHA/ASA Guidelines for:
Stroke Prevention in NON-Valvular AFib
- *AC** may start within 14 days AFTER stroke
- unless HIGH RISK for hemorrhage*
For patients UNABLE to take AC therapy
ASPIRIN ALONE > ASA + clopidogrel
Anticoagulant + Antiplatelet
ONLY recommended with CLINICALLY APPARENT CAD:
ACS or Cardiac stent placement